Drug Recalls & Alerts
View the latest FDA drug recalls and alerts.
! DRUG RECALL - 1/12/2017
FDA Drug Recalls
Drug recalls are actions taken by drug manufacturer’s to remove a product from the market. Recalls may be conducted by the manufacturer on their own initiative, by request of the FDA, or mandated by the FDA. Below is a highlight of the most relevant drug recalls.
| Drug Recalls | |||
|---|---|---|---|
| Drug Name | Type of Recall | Reason for Recall | Recalling Firm |
| Docusate 10 mg/mL oral syringe | Voluntary | Microbial contamination of non-sterile products; microbial contamination with B. cepacia | US Compounding, Inc. |
| Bupivacaine HCI 0.25% inj. | Voluntary | Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial. | Hospira Inc., A Pfizer Company |
| Lamotrigine 200 MG orally disintegrating tablets | Voluntary | Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs | Impax Laboratories, Inc. |
| GlucaGen HypoKit 1 mg/vial | Voluntary | Defective delivery system: detached needles on the syringe in the kit. | Novo Nordisk Inc. |
| Hyoscyamine sulfate 0.125 mg tablets/SL tablets/orally disintegrating tablets | Voluntary | Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets. | Virtus Pharmaceuticals OPCO II L |
| Lidocaine HCI/sodium bicarbonate 1%/5% 0.5 mL syringe | Voluntary | Non-Sterility: failed sterility test result. | Guardian Pharmacy Services |